Leonteq Securities AG’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Leonteq Securities AG’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,262	Closed	-$558	–	1372
2026 Q1	$558	Hold	2,262	–	–	﹤0.01%	1221
2025 Q4	$950	Hold	2,262	–	–	﹤0.01%	1346
2025 Q3	$1.52K	Hold	2,262	–	–	﹤0.01%	1232
2025 Q2	$1.22K	Hold	2,262	–	–	﹤0.01%	1193
2025 Q1	$1.48K	Buy	+2,262	New	+$2.4K	﹤0.01%	1156
2022 Q4	–	Sell	-11,000	Closed	-$53.9K	–	1347
2022 Q3	$53.9K	Buy	11,000 +1,000	+10%	+$5.14K	﹤0.01%	791
2022 Q2	$41.4K	Buy	10,000 +3,000	+43%	+$13K	﹤0.01%	871
2022 Q1	$40.7K	Buy	+7,000	New	+$41.6K	﹤0.01%	901
2021 Q1	–	Sell	-2,000	Closed	-$31.2K	–	1089
2020 Q4	$31.2K	Buy	+2,000	New	+$23.4K	﹤0.01%	854

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Leonteq Securities AG's SGMO Position: Q2 2026 in Review

Leonteq Securities AG sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 2,262 shares — an estimated $558 sold.

Leonteq Securities AG first reported a position in SGMO in Q4 2020 and held it in 9 quarters. The position peaked at $53.9K in Q3 2022. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Leonteq Securities AG reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Leonteq Securities AG sold 2,262 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $558.
Leonteq Securities AG first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 9 quarters.
Leonteq Securities AG's SANGAMO THERAPEUTICS INC position peaked at $53.9K in Q3 2022.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.